Detection of DNS Traffic Anomalies in Large Networks

Almost every Internet communication is preceded by a translation of a DNS name to an IP address. Therefore monitoring of DNS traffic can effectively extend capabilities of current methods for network traffic anomaly detection. In order to effectively monitor this traffic, we propose a new flow metering algorithm that saves resources of a flow exporter. Next, to show benefits of the DNS traffic monitoring for anomaly detection, we introduce novel detection methods using DNS extended flows. The evaluation of these methods shows that our approach not only reveals DNS anomalies but also scales well in a campus network.Téměř každá síťová komunikace je předcházena překladem doménového jména na IP adresu. Měření a následná analýza DNS provozu může účinně rozšířit schopnosti současných metod pro detekci anomálií v celkovém síťovém provozu. Aby bylo možné tento provoz efektivně sledovat, navrhujeme v článku nový algoritmus pro sběr a export síťových toků šetřicí zdroje exportéru. Dále, abychom ukázali výhody monitorování DNS provozu pro detekci anomálií, představujeme nové detekční metody využívající síťové toky rozšířené o informace z DNS paketů. Z vyhodnocení těchto metod vyplývá, že navržený přístup umožňuje úspěšně detekovat anomálie v DNS provozu a to dokonce i v rozsáhlých, univerzitních sítích

Brucellosis Presenting with Febrile Pancytopenia: An Atypical Presentation of a Common Disease and Review of Brucellosis

Brucellosis is a febrile zoonotic disease caused by one of several species of the Gram-negative coccobacillus Brucella. It is endemic to the Middle East, sub-Saharan Africa, and Central America. However, cases have also been reported in the United States. Infection is most commonly transmitted via unpasteurized dairy products or through occupational exposure to livestock. The clinical presentation is highly variable; symptoms may include fever, myalgias, night sweats, weight loss, nausea, and vomiting. Less common features include orchitis, osteomyelitis, and sacroiliitis. In addition, pregnant women who contract brucellosis face a markedly increased risk of miscarriage. A presumptive diagnosis is typically established through correlation of patient history and classic laboratory findings, which include transaminitis, anemia, and leukopenia with relative lymphocytosis. Definitive diagnosis can only be established through isolation of Brucella species from blood or tissues. Treatment involves a prolonged course of multiple antibiotics; six weeks of combination therapy with aminoglycoside or rifampin and tetracycline represents the most common regimen. Healthy individuals who develop brucellosis have a generally favorable prognosis, as the case fatality rate is less than 2%. Nevertheless, early detection and treatment are essential to reduce the risk of long-term sequelae that may result from chronic, indolent disease

Brucellosis Presenting with Febrile Pancytopenia: An Atypical Presentation of a Common Disease and Review of Brucellosis

Brucellosis is a febrile zoonotic disease caused by one of several species of the Gram-negative coccobacillus Brucella. It is endemic to the Middle East, sub-Saharan Africa, and Central America. However, cases have also been reported in the United States. Infection is most commonly transmitted via unpasteurized dairy products or through occupational exposure to livestock. The clinical presentation is highly variable; symptoms may include fever, myalgias, night sweats, weight loss, nausea, and vomiting. Less common features include orchitis, osteomyelitis, and sacroiliitis. In addition, pregnant women who contract brucellosis face a markedly increased risk of miscarriage. A presumptive diagnosis is typically established through correlation of patient history and classic laboratory findings, which include transaminitis, anemia, and leukopenia with relative lymphocytosis. Definitive diagnosis can only be established through isolation of Brucella species from blood or tissues. Treatment involves a prolonged course of multiple antibiotics; six weeks of combination therapy with aminoglycoside or rifampin and tetracycline represents the most common regimen. Healthy individuals who develop brucellosis have a generally favorable prognosis, as the case fatality rate is less than 2%. Nevertheless, early detection and treatment are essential to reduce the risk of long-term sequelae that may result from chronic, indolent disease.</jats:p